Carret Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$759K Buy
3,380
+10
+0.3% +$2.49K 0.07% 169
2025
Q4
$812K Buy
+3,370
New +$862K 0.08% 167

Other funds holding RMD

Carret Asset Management's RMD Position: Q1 2026 in Review

Carret Asset Management increased its ResMed (RMD) stake by 0.3% in Q1 2026, buying an estimated $2.49K and bringing the position to 3,380 shares worth $759K. The position accounts for 0.07% of the portfolio, ranked #169.

Carret Asset Management first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $812K in Q4 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Carret Asset Management held 3,380 shares of ResMed worth $759K as of Q1 2026.
  • Carret Asset Management bought 10 ResMed shares in Q1 2026, an estimated $2.49K.
  • ResMed made up 0.07% of Carret Asset Management's portfolio in Q1 2026, its #169 holding.
  • Carret Asset Management first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
  • Carret Asset Management's ResMed position peaked at $812K in Q4 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Carret Asset Management's 13F filing for Q1 2026, filed 15 May 2026.